-
NBIX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Neurocrine Biosciences (NBIX)
Company Profile
Quarter (USD) | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 147.70 mm | 147.70 mm | 147.70 mm | 147.70 mm | 147.70 mm | 147.70 mm |
Cash burn (monthly) | 85.53 mm | 1.71 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 495.96 mm | 9.91 mm | n/a | n/a | n/a | n/a |
Cash remaining | -348.26 mm | 137.79 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | -4.1 | 80.7 | n/a | n/a | n/a | n/a |
13F holders | Current |
---|---|
Total holders | 583 |
Opened positions | 127 |
Closed positions | 58 |
Increased positions | 222 |
Reduced positions | 163 |
13F shares | Current |
---|---|
Total value | 12.18 tn |
Total shares | 93.58 mm |
Total puts | 227.20 k |
Total calls | 660.90 k |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
BLK BlackRock | 14.19 mm | $1.95 tn |
Vanguard | 10.06 mm | $1.38 tn |
STT State Street | 4.61 mm | $634.43 bn |
Renaissance Technologies | 2.47 mm | $339.79 bn |
JPM JPMorgan Chase & Co. | 2.36 mm | $325.28 bn |
BLVGF Bellevue | 1.90 mm | $261.39 bn |
Geode Capital Management | 1.82 mm | $250.11 bn |
T. Rowe Price | 1.80 mm | $247.65 mm |
MS Morgan Stanley | 1.54 mm | $212.68 bn |
Dodge & Cox | 1.28 mm | $176.33 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Dec 24 | Ingrid Delaet | Common Stock | Sell | Dispose S | No | Yes | 135 | 1,091 | 147.29 k | 2,507 |
17 Dec 24 | Ingrid Delaet | Common Stock | Option exercise | Acquire M | No | No | 79.02 | 1,091 | 86.21 k | 3,598 |
17 Dec 24 | Ingrid Delaet | NQSO Common Stock | Option exercise | Dispose M | No | No | 79.02 | 1,091 | 86.21 k | 2,990 |
17 Dec 24 | Roberts Eiry | Stock Option Common Stock | Grant | Acquire A | No | No | 136.69 | 27,770 | 3.80 mm | 27,770 |
17 Dec 24 | Roberts Eiry | RSU Common Stock | Grant | Acquire A | No | No | 0 | 5,487 | 0.00 | 5,487 |
29 Nov 24 | Jude Onyia | Common Stock | Sell | Dispose S | No | Yes | 126.286 | 2,331 | 294.37 k | 15,449 |
29 Nov 24 | Jude Onyia | Common Stock | Option exercise | Acquire M | No | No | 0 | 4,426 | 0.00 | 17,780 |
29 Nov 24 | Jude Onyia | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 4,426 | 0.00 | 4,426 |
8 Nov 24 | Roberts Eiry | Common Stock | Option exercise | Acquire M | No | No | 79.02 | 1 | 79.02 | 31,061 |
8 Nov 24 | Roberts Eiry | Common Stock | Option exercise | Acquire M | No | No | 102.9 | 971 | 99.92 k | 31,060 |